Prevalence of Anal Dysplasia and Cancer in Women [clinicaltrials:NCT02140021]
Prevalence of Anal Dysplasia and Cancer in Women [clinicaltrials:NCT02140021]
Bio2RDF identifier
NCT02140021
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT02140021
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
biospec retention [clinicaltrials_vocabulary:biospec-retention]
Samples With DNA
biospec_descr [clinicaltrials_vocabulary:biospec_descr]
All patients undergo anal Pap and anal HPV testing.
brief summary [clinicaltrials_vocabulary:brief-summary]
The goal of this clinic ...... the cervix, vagina, or vulva.
brief title [clinicaltrials_vocabulary:brief-title]
Prevalence of Anal Dysplasia and Cancer in Women
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Anal cancer as well as ...... at the Harris Health System.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2014-05-14T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
keyword [clinicaltrials_vocabulary:keyword]
Anal pap test
Carcinoma of the cervix
Carcinoma of the vagina
Carcinoma of the vulva
Gynecological Cancer
High-grade dysplasia
Invasive squamous cell carcinoma
Malignant Female Reproductive System Neoplasm
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2015-06-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT02140021
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Prevalence of Anal Dysplasia a ...... nd Vulvar Dysplasia and Cancer
org study id [clinicaltrials_vocabulary:org-study-id]
overall contact [clinicaltrials_vocabulary:overall-contact]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2020-10-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2014-10-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2015-06-01T00:00:00Z
identifier
clinicaltrials:NCT02140021
title
Prevalence of Anal Dysplasia and Cancer in Women
@en
type
label
Prevalence of Anal Dysplasia and Cancer in Women [clinicaltrials:NCT02140021]
@en